Published by Frank Prenesti on 2nd May 2023
(Sharecast News) - AstraZeneca said it was disappointed with a decision by a panel of US Food and Drug Administration advisers to restrict use of its treatment for a type of prostate cancer.
URL: http://www.digitallook.com/dl/news/story/33473436/...